Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on September 15, 2003

Circulation. 2003
Published online before print September 15, 2003, doi: 10.1161/01.CIR.0000087595.17277.73
A more recent version of this article appeared on September 30, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/13/1633    most recent
01.CIR.0000087595.17277.73v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, R.-P.
Right arrow Articles by Cheng, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, R.-P.
Right arrow Articles by Cheng, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Heart failure - basic studies

Submitted on January 15, 2003
Revised on May 20, 2003
Accepted on May 21, 2003

Enhanced Gi Signaling Selectively Negates {beta}2-Adrenergic Receptor (AR)- but Not {beta}1-AR-Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts

Rui-Ping Xiao MD, PhD*, Sheng-Jun Zhang MD, Khalid Chakir PhD, Pavel Avdonin PhD, Weizhong Zhu MD, PhD, Richard A. Bond PhD, C. William Balke MD, PhD, Edward G. Lakatta MD, and Heping Cheng PhD

From the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Md (R.X., S.Z., K.C., P.A., W.Z., E.G.L., H.C.); the Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Tex (R.A.B.); and the Departments of Physiology and Medicine, University of Maryland at Baltimore, and Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Md (C.W.B.).

* To whom correspondence should be addressed. E-mail: xiaor{at}grc.nia.nih.gov.

Background--Myocardial contractile response to {beta}1- and {beta}2-adrenergic receptor (AR) stimulation is severely impaired in chronic heart failure, in which Gi signaling and the ratio of {beta}2/{beta}1 are often increased. Because {beta}2-AR but not {beta}1-AR couples to Gs and Gi with the Gi coupling negating the Gs-mediated contractile response, we determined whether the heart failure-associated augmentation of Gi signaling contributes differentially to the defects of these {beta}-AR subtypes and, if so, whether inhibition of Gi or selective activation of {beta}2-AR/Gs by ligands restores {beta}2-AR contractile response in the failing heart.

Methods and Results--Cardiomyocytes were isolated from 18- to 24-month-old failing spontaneously hypertensive (SHR) or age-matched Wistar-Kyoto (WKY) rat hearts. In SHR cardiomyocytes, either {beta}-AR subtype-mediated inotropic effect was markedly diminished, whereas Gi proteins and the {beta}2/{beta}1 ratio were increased. Disruption of Gi signaling by pertussis toxin (PTX) enabled {beta}2- but not {beta}1-AR to induce a full positive inotropic response in SHR myocytes. Furthermore, screening of a panel of {beta}2-AR ligands revealed that the contractile response mediated by most {beta}2-AR agonists, including zinterol, salbutamol, and procaterol, was potentiated by PTX, indicating concurrent Gs and Gi activation. In contrast, fenoterol, another {beta}2-AR agonist, induced a full positive inotropic effect in SHR myocytes even in the absence of PTX.

Conclusions--We conclude that enhanced Gi signaling is selectively involved in the dysfunction of {beta}2- but not {beta}1-AR in failing SHR hearts and that disruption of Gi signaling by PTX or selective activation of {beta}2-AR/Gs signaling by fenoterol restores the blunted {beta}2-AR contractile response in the failing heart.


Key words: receptors, adrenergic, beta • heart failure • proteins • contractility




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Lyashkov, T. M. Vinogradova, I. Zahanich, Y. Li, A. Younes, H. B. Nuss, H. A. Spurgeon, V. A. Maltsev, and E. G. Lakatta
Cholinergic receptor signaling modulates spontaneous firing of sinoatrial nodal cells via integrated effects on PKA-dependent Ca2+ cycling and IKACh
Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H949 - H959.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Hamdani, W. J. Paulus, L. van Heerebeek, A. Borbely, N. M. Boontje, M. J. Zuidwijk, J. G.F. Bronzwaer, W. S. Simonides, H. W. M. Niessen, G. J. M. Stienen, et al.
Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction
Eur. Heart J., August 1, 2009; 30(15): 1863 - 1872.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Seifert and S. Dove
Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities
Mol. Pharmacol., January 1, 2009; 75(1): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Y.-H. Woo, T.-B. Wang, X. Zeng, W. Zhu, D. R. Abernethy, I. W. Wainer, and R.-P. Xiao
Stereochemistry of an Agonist Determines Coupling Preference of {beta}2-Adrenoceptor to Different G Proteins in Cardiomyocytes
Mol. Pharmacol., January 1, 2009; 75(1): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Siedlecka, M. Arora, T. Kolettis, G. K. R. Soppa, J. Lee, M. A. Stagg, S. E. Harding, M. H. Yacoub, and C. M. N. Terracciano
Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1917 - H1926.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. Stones, A. Natali, R. Billeter, S. Harrison, and E. White
Voluntary exercise-induced changes in {beta}2-adrenoceptor signalling in rat ventricular myocytes
Exp Physiol, September 1, 2008; 93(9): 1065 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. DeSantiago, X. Ai, M. Islam, G. Acuna, M. T. Ziolo, D. M. Bers, and S. M. Pogwizd
Arrhythmogenic Effects of {beta}2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load
Circ. Res., June 6, 2008; 102(11): 1389 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Wang, J.-F. Du, F. Wu, and H.-C. Wang
Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2540 - H2546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. P. Collis, S. Srivastava, W. A. Coetzee, and M. Artman
beta2-Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2826 - H2835.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-H. Zhang, G.-R. Li, and J.-P. Bourreau
The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2888 - H2893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Galandrin and M. Bouvier
Distinct Signaling Profiles of beta1 and beta2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy
Mol. Pharmacol., November 1, 2006; 70(5): 1575 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
Relative myotoxic and haemodynamic effects of the {beta}-agonists fenoterol and clenbuterol measured in conscious unrestrained rats
Exp Physiol, November 1, 2006; 91(6): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. Hulme, R. E. Westenbroek, T. Scheuer, and W. A. Catterall
Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation
PNAS, October 31, 2006; 103(44): 16574 - 16579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mittra and J.-P. Bourreau
Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1842 - H1847.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-S. Zhang, H.-J. Cheng, K. Onishi, N. Ohte, T. Wannenburg, and C.-P. Cheng
Enhanced Inhibition of L-type Ca2+ Current by {beta}3-Adrenergic Stimulation in Failing Rat Heart
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1203 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Zhu, X. Zeng, M. Zheng, and R.-P. Xiao
The Enigma of {beta}2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly
Circ. Res., September 16, 2005; 97(6): 507 - 509.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J.-Q. He, R. C. Balijepalli, R. A. Haworth, and T. J. Kamp
Crosstalk of {beta}-Adrenergic Receptor Subtypes Through Gi Blunts {beta}-Adrenergic Stimulation of L-Type Ca2+ Channels in Canine Heart Failure
Circ. Res., September 16, 2005; 97(6): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W.-Z. Zhu, K. Chakir, S. Zhang, D. Yang, C. Lavoie, M. Bouvier, T. E. Hebert, E. G. Lakatta, H. Cheng, and R.-P. Xiao
Heterodimerization of {beta}1- and {beta}2-Adrenergic Receptor Subtypes Optimizes {beta}-Adrenergic Modulation of Cardiac Contractility
Circ. Res., August 5, 2005; 97(3): 244 - 251.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Ahmet, M. Krawczyk, P. Heller, C. Moon, E. G. Lakatta, and M. I. Talan
Beneficial Effects of Chronic Pharmacological Manipulation of {beta}-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy
Circulation, August 31, 2004; 110(9): 1083 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Morimoto, H. Hasegawa, H.-J. Cheng, W. C. Little, and C.-P. Cheng
Endogenous {beta}3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2425 - H2433.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. F. Heubach, U. Ravens, and A. J. Kaumann
Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart
Mol. Pharmacol., May 1, 2004; 65(5): 1313 - 1322.
[Abstract] [Full Text]